The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Kenneth J. Valenzano

Departments of Molecular Pharmacology

Pudue Pharma Discovery Research

6 Cedarbrook Dr.




Name/email consistency: high



  • Departments of Molecular Pharmacology, Pudue Pharma Discovery Research, 6 Cedarbrook Dr., Cranbury, USA. 2003 - 2005


  1. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. Valenzano, K.J., Tafesse, L., Lee, G., Harrison, J.E., Boulet, J.M., Gottshall, S.L., Mark, L., Pearson, M.S., Miller, W., Shan, S., Rabadi, L., Rotshteyn, Y., Chaffer, S.M., Turchin, P.I., Elsemore, D.A., Toth, M., Koetzner, L., Whiteside, G.T. Neuropharmacology (2005) [Pubmed]
  2. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted mu opioid agonist with antihyperalgesic activity: I. In vitro pharmacological characterization and pharmacokinetic properties. Valenzano, K.J., Miller, W., Chen, Z., Shan, S., Crumley, G., Victory, S.F., Davies, E., Huang, J.C., Allie, N., Nolan, S.J., Rotshteyn, Y., Kyle, D.J., Broglé, K. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  3. Current perspectives on the therapeutic utility of VR1 antagonists. Valenzano, K.J., Sun, Q. Curr. Med. Chem. (2004) [Pubmed]
  4. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. Valenzano, K.J., Grant, E.R., Wu, G., Hachicha, M., Schmid, L., Tafesse, L., Sun, Q., Rotshteyn, Y., Francis, J., Limberis, J., Malik, S., Whittemore, E.R., Hodges, D. J. Pharmacol. Exp. Ther. (2003) [Pubmed]
WikiGenes - Universities